Open AccessSAFETY, PHARMACOKINETICS AND VIROLOGICAL/IMMUNOLOGICAL EFFICACY OF ABT-538, A HIV-PROTEASE INHIBITOR. A RANDOMISED, PLACEBO-CONTROLLED PHASE I/II STUDY
Author(s) -
Sven A. Danner,
Danielle Cooper,
Francesc Gudiol,
J.C. De La Torre Gonzales,
Jordi Tor,
Rafael Rubio,
Joaquin Valdes,
John M. Leonard
Publication year - 1994
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/00002030-199411004-00036
Subject(s) - protease inhibitor (pharmacology) , pharmacokinetics , placebo , indinavir , virology , medicine , human immunodeficiency virus (hiv) , pharmacology , sida , antiretroviral therapy , viral disease , viral load , pathology , alternative medicine